Calendar Pfizer, Inc. Deutsche Boerse AG

Equities

PFE

US7170811035

Market Closed - Deutsche Boerse AG 19:48:29 17/05/2024 BST 5-day change 1st Jan Change
26.3 EUR -1.22% Intraday chart for Pfizer, Inc. +0.84% +0.75%

Chart calendar Pfizer, Inc.

15b4c16.RqhwvZGfAjXHfyWPczfKEodHFup86YQJy43e6wMMRUM.A8oFi9DTenr0FGq6P1q-IL8oZJ4pmO5zvtLohi5WBxo12QHn-dlaQqYsaA~2763d19cc253a6bb8b640f4ad4cfe052

Upcoming events on Pfizer, Inc.

31/05/2024 20:45 American Society of Clinical Oncology Annual Meeting - Abstract No: LBA8503
01/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 3108
01/06/2024 21:00 American Society of Clinical Oncology Annual Meeting - Abstract No: LBA7005
01/06/2024 21:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 5005
01/06/2024 21:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 3006
01/06/2024 22:30 American Society of Clinical Oncology Annual Meeting - Abstract No: 8521
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 4563
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 4562
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 5063
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 5061
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 5021
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 1105
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 1111
03/06/2024 14:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 4503
03/06/2024 14:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 4502

Past events on Pfizer, Inc.

08/05/2024 Ex-dividend day
01/05/2024 15:00 Q1 2024 Earnings Call
01/05/2024 11:45 Q1 2024 Earnings Release
25/04/2024 14:00 Annual General Meeting
12/03/2024 12:00 Leerink Partners Global Biopharma Conference
04/03/2024 16:10 TD Cowen Health Care Conference
29/02/2024 18:00 Investor Day - Oncology Innovation
30/01/2024 15:00 Q4 2023 Earnings Call
30/01/2024 11:45 Q4 2023 Earnings Release
24/01/2024 Ex-dividend day
08/01/2024 23:00 JPMorgan Healthcare Conference
13/12/2023 13:30 Q4 2024 Guidance Call
12/12/2023 01:15 American Society of Hematology Meeting - Abstract Number -1054
12/12/2023 00:30 American Society of Hematology Meeting - Abstract Number -1057
10/12/2023 00:45 American Society of Hematology Meeting - Abstract Number -274
10/12/2023 00:30 American Society of Hematology Meeting - Abstract Number -285
09/12/2023 17:45 American Society of Hematology Meeting - Abstract Number -14
28/11/2023 15:50 Evercore ISI HealthCONx Conference
09/11/2023 17:35 Truist Securities Healthcare Conference
08/11/2023 Ex-dividend day

Past dividends on Pfizer, Inc.

08/05/2024 Quarterly 0.42 USD
24/01/2024 Quarterly 0.42 USD
08/11/2023 Quarterly 0.41 USD
26/07/2023 Quarterly 0.41 USD
10/05/2023 Quarterly 0.41 USD
25/01/2023 Quarterly 0.41 USD
02/11/2022 Quarterly 0.4 USD
27/07/2022 Quarterly 0.4 USD
11/05/2022 Quarterly 0.4 USD
26/01/2022 Quarterly 0.4 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
51 750
51 807
-0.11%
41 908
48 014
-12.72%
81 288
81 781
-0.6%
100 330
100 373
-0.04%
58 496
59 105
-1.03%

60 407

EBITDA
Million USD
Released
Forecast
Spread
21 097
22 824
-7.57%
17 801
21 398
-16.81%
25 426
29 444
-13.65%
42 336
44 597
-5.07%
15 590
11 249
38.59%

21 189

EBIT
Million USD
Released
Forecast
Spread
19 420
19 883
-2.33%
13 024
17 362
-24.99%
20 235
26 662
-24.11%
37 272
40 403
-7.75%
9 300
8 509
9.3%

17 050

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
17 682
22 426
-21.15%
7 497
13 166
-43.06%
24 311
19 569
24.23%
34 729
39 058
-11.08%
1 058
2 301
-54.02%

11 020

Net income
Million USD
Released
Forecast
Spread
16 273
19 053
-14.59%
9 616
16 066
-40.15%
21 979
22 567
-2.6%
31 372
33 053
-5.09%
2 119
3 040
-30.29%

7 775

EPS
USD
Released
Forecast
Spread
2,87
3,40
-15.62%
1,71
3,07
-44.24%
3,85
3,89
-0.9%
5,47
5,85
-6.45%
0,37
0,72
-48.44%

1,44

Announcement Date28/01/2002/02/2108/02/2231/01/2330/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
25 661
24 734
3.75%
27 742
26 199
5.89%
22 638
21 091
7.33%
24 290
24 393
-0.42%
18 282
16 488
10.88%
12 734
13 398
-4.96%
13 232
13 429
-1.47%
14 249
14 396
-1.02%
14 879
13 923
6.87%

13 050


14 847


17 770


15 680


13 725

EBITDA
Million USD
Released
Forecast
Spread
11 135
13 710
-18.78%
13 583
12 434
9.25%
10 325
10 332
-0.06%
6 772
7 436
-8.92%
7 857
7 513
4.58%
4 925
4 000
23.13%
-1 244
-1 511
17.64%
1 340
-1 298
203.24%

4 403


3 759


4 681


4 537







EBIT
Million USD
Released
Forecast
Spread
9 948
9 738
2.16%
12 408
11 055
12.24%
9 142
9 092
0.55%
5 253
6 886
-23.71%
6 370
6 471
-1.56%
3 319
3 634
-8.68%
-1 625
-1 827
11.07%
-330
-1 404
76.5%
5 912
3 667
61.24%

3 423


3 804


3 977







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
9 050








5 231
7 425
-29.55%






-3 352
2 207
-251.88%
-4 129
-3 139
-31.54%
3 421
2 992
14.34%

1 962


2 926


3 380







Net income
Million USD
Released
Forecast
Spread
7 864
8 418
-6.58%
9 906
9 799
1.09%
8 608
7 631
12.8%
4 995
5 667
-11.86%
5 543
4 495
23.31%
2 327


-2 382
-3 241
26.49%
-3 369
-2 371
-42.12%
3 115
1 951
59.69%

1 496


2 046


2 679







EPS
USD
Released
Forecast
Spread
1,37
1,60
-14.17%
1,73
1,64
5.73%
1,51
1,37
10.21%
0,87
0,69
25.48%
0,97
0,85
14.79%
0,41


-0,42
-0,51
16.83%
-0,60
-0,43
-41.06%
0,55
0,34
61.01%

0,25


0,36


0,47







Announcement Date03/05/2228/07/2201/11/2231/01/2302/05/2301/08/2331/10/2330/01/2401/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise